August 7, 2018 | Angela Duffy, Basel, Dan Coffin, EphMRA, Events, Healthcare Market Research, Richard Head
EU Directors Angela Duffy, Richard Head and Dan coffin attended the EphMRA annual conference in Basel.
The conference kicked off with a fascinating and very personal keynote paper by Ian Talmage, Senior Advisor to Bayer Global Strategic Marketing, on the magnitude of changes our industry has faced over the years, reflecting upon the future landscape, where changes are likely to be and the challenges that sit ahead. This set the underlying tone for the conference, with many papers focusing on technology, behavioural science, patient engagement, data analytics, and collaborative approaches to optimising and enhancing insights…Read the full article:Â https://bit.ly/2OjctfJ
This content was provided by Inizio
Latest Content from Inizio
What does the future hold for the US pharma industry?
Pharmaceutical market research is still evolving in many emerging markets and so finding the insights you require can be a challenge.
Pharma companies are increasingly looking for ways to provide “beyond the pill” services to support patients with the management of their disease. Adherence tools and programs encourage patients to stay compliant with their treatment…
Treatment initiation is a key focus for many pharma companies as part of their strategy to increase script writing and drive greater revenues.
One of the most consistent issues researchers face with segmentation is ensuring that it is actionable.
Exploring the opportunities for pharma in the ASEAN region and factors to consider when conducting healthcare market research.
Understanding the opportunities for biosimilars and the threats to innovator biologics
The Chinese healthcare market is experiencing a period of great change. Utilising local knowledge and detailed case studies, this webinar examines the likely impact on the patient journey and considers…
Utilising the benefits of mobile technology
Presenting a window on the world of your customer
